Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64,389Revenue $M21,848Net Margin (%)11.0Z-Score3.9
Enterprise Value $M64,794EPS $1.6Operating Margin %11.9F-Score7
P/E(ttm))28.0Cash Flow Per Share $6.7Pre-tax Margin (%)11.6Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %-1.3Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %-22.6Current Ratio1.9Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %56.7ROA % (ttm)5.8Higher Current Ratio y-yY
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)10.2Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M1,502ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 42.669%New holding, 1665688 sh.1,665,688
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 42.669%Reduce -23.73%932,181
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 42.6611%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 42.6611%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 42.6611%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 42.6616%New holding, 3250000 sh.3,250,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 42.6616%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 42.6616%Sold Out0
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 42.6622%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 42.6622%New holding, 118700 sh.118,700
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 42.6622%Reduce -4.79%13,727,856
ABTJohn Hussman 2013-06-30 Sold Out -0.52%$34.88 - $38.56
($36.68)
$ 42.6616%Sold Out0
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 42.6616%Reduce -18.79%7,591,400
ABTPRIMECAP Management 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 42.6626%Add 58.55%11,683,747
ABTGeorge Soros 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 42.6626%Add 93.84%1,140,752
ABTMario Gabelli 2013-03-31 Add0.01%$31.34 - $35.32
($33.84)
$ 42.6626%Add 40.97%84,215
ABTDaniel Loeb 2013-03-31 Sold Out -1.1%$31.34 - $35.32
($33.84)
$ 42.6626%Sold Out0
ABTJoel Greenblatt 2013-03-31 Sold Out -0.06%$31.34 - $35.32
($33.84)
$ 42.6626%Sold Out0
ABTMeridian Funds 2013-03-31 Sold Out -0.02%$31.34 - $35.32
($33.84)
$ 42.6626%Sold Out0
ABTMason Hawkins 2012-12-31 Add1.43%$14.4 - $16.51
($15.11)
$ 42.66182%Add 85.61%14,754,193
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Jean-Marie Eveillard 2014-06-301,665,6880.110.16New Buy
ABT Ray Dalio 2014-06-3017,70000.01+2.91%
ABT PRIMECAP Management 2014-06-3017,127,0631.140.77+0.23%
ABT Vanguard Health Care Fund 2014-06-307,591,4000.510.82
ABT Dodge & Cox 2014-06-3036,89800-0.14%
ABT Mason Hawkins 2014-06-3013,687,8770.913-0.43%
ABT Mario Gabelli 2014-06-30160,7070.010.03-4.62%
ABT George Soros 2014-06-30932,1810.060.29-23.73%
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.959.27view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.959.27view
Blaser Brian JExecutive Vice President 2014-03-03Sell1,441$39.019.1view
ASHLEY RICHARD WExecutive Vice President 2014-03-03Sell2,098$399.13view
ALLEN HUBERT LExecutive Vice President 2014-03-03Sell1,543$39.039.04view
Funck Robert EVice President, Controller 2014-03-03Sell1,413$38.979.21view
FREYMAN THOMAS CExecutive Vice President 2014-03-03Sell2,984$39.18.85view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.378.1view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.019.1view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.019.1view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Weekly 52-Week Highs Highlight: ABT, SWK, LMT, AMGN Sep 13 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Abbott: A Brighter Future Aug 28 2014 
    6 Stocks Currently Trading Below Fair Value Jul 02 2014 
    Why I Bought Baxter International Jun 19 2014 
    Two Stocks On My Watch List For June 2014 May 29 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 
    Different Opinions on Bio-Rad Laboratories Apr 03 2014 
    Absolute and Relative Valuation Models Indicate the Same: Abbot Is a Buy Mar 31 2014 


    More From Other Websites
    New York Files an Antitrust Suit Against the Maker of an Alzheimer’s Drug Sep 15 2014
    Abbott Labs Presents Positive One-Year Data on Absorb Sep 15 2014
    Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart... Sep 15 2014
    Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session Sep 15 2014
    3:08 am Abbott Labs: ABSORB II study shows Abbott's Dissolving Heart Device comparable to the... Sep 15 2014
    ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent Sep 14 2014
    Abbott dissolving stent has lower angina rate vs metal stent -study Sep 14 2014
    Abbott’s Dissolving Heart Stent Clears Arteries in Trial Sep 14 2014
    Abbott Labs (ABT) to Repurchase Shares for $3B Sep 12 2014
    [$$] Abbott Labs Sets $3 Billion Buyback Sep 11 2014
    Abbott Laboratories (ABT) Declares Quarterly Dividend, Announces Share Buyback Sep 11 2014
    Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend Sep 11 2014
    Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow... Sep 11 2014
    [video] Sen. Schumer's inversion compromise Sep 10 2014
    [video] Pursuing tax inversion solutions Sep 08 2014
    FTC sues AbbVie, Teva over generic AndroGel Sep 08 2014
    New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs Sep 08 2014
    Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark Sep 05 2014
    Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential Sep 05 2014
    [video] Diabetes monitoring goes mobile Sep 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK